Craft

Amyris

Total Funding

$551.9 M

Revenue

$269.8 M

FY, 2022

Amyris Summary

Company Summary

Overview
Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. It produces molecules from sugars for use in vaccine adjuvants, fragrances, sweeteners, and cosmetic ingredients. The company supplies ingredients and manufacturing services to ingredient distributors, brand owners, and manufacturers in the personal care, food and beverage, health, and industrial chemical sectors.
Type
Private
Status
Active
Founded
2003
HQ
Emeryville, CA, US | view all locations
Website
https://amyris.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Han Kieftenbeld

    Han Kieftenbeld, Interim Chief Executive Officer and Chief Financial Officer

  • Wojciech Adam Blaziak

    Wojciech Adam Blaziak, Chief Manufacturing & Supply Chain Officer

  • Annie Tsong

    Annie Tsong, Chief Strategy Officer & Product & Ingredients

  • Doris Choi

    Doris Choi, General Counsel & Secretary

LocationsView all

2 locations detected

  • Emeryville, CA HQ

    United States

    5885 Hollis Street, Suite 100

  • Sao Paulo, SP

    Brazil

    Rua John Dalton, 301 – Bloco B – Edificio 3 Condominio Techno Plaza

Amyris Financials

Summary Financials

Revenue (Q1, 2023)
$56.1M
Gross profit (Q1, 2023)
$5.0M
Net income (Q1, 2023)
($201.8M)
Cash (Q1, 2023)
$11.2M
EBIT (Q1, 2023)
($185.5M)

Footer menu